Today on Outliving Cancer, Dr. Nagourney discusses the metabolic basis of human malignancy -- the history, present and future -- and new groundbreaking studies.

Today on Outliving Cancer, Dr. Nagourney introduces colleague and research collaborator Dr. Paulo D’Amora on using quantitative Mass Spectrometry in identifying metabolic signatures to determine a predisposition to disease.

Dr. Nagourney discusses on today’s episode a recent study he and colleagues conducted that was able to identify gynecologic cancer patients at the highest risk of relapse. The results could herald a future in which oncologists could use a blood test done at the time of diagnosis to better manage patients with advanced gynecologic malignancies.

Today Dr. Robert Nagourney discusses treatment options for Triple Negative Breast Cancer, which accounts for 10 to 15 percent of all breast cancers and tends to grow and spread faster than other breast cancers.

Dr. Robert Nagourney today discusses an important presentation conducted at an American Association for Cancer Research Special Conference on Pancreatic Cancer.

Today Dr. Nagourney discusses the management of breast cancer, specifically HER2-positive breast cancer, and visits with a patient who has a remarkable story and shares her experience.